Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH

Detecting and treating JIA-associated uveitis

Detecting and treating JIA-associated uveitis

A closer look at the SHARE recommendations

In this medwireNews podcast, Athimalaipet Ramanan outlines the importance of the SHARE recommendations for children with JIA-associated uveitis, and discusses how rheumatologists and ophthalmologists can work together.

11-05-2018 | Juvenile idiopathic arthritis | Feature | News

Managing JIA-associated uveitis: An ophthalmologist’s perspective

medwireNews talks to consultant ophthalmologist Carlos Pavesio about the SHARE initiative recommendations on treating JIA-associated uveitis.

10-04-2018 | Juvenile idiopathic arthritis | News

Recommendations for managing JIA-associated uveitis published

The SHARE initiative has developed consensus evidence-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis.

10-04-2018 | Article

Editorial board comment

Comment on: Recommendations for managing JIA-associated uveitis published

Image Credits